Skip to main
CL

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive (CL) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 33%
Buy 40%
Hold 27%
Sell 0%
Strong Sell 0%

Bulls say

Colgate-Palmolive has demonstrated a strategic increase in advertising spending as a percentage of sales, rising from 11.6% in 2021 to 13.5% in 2024, which is projected to remain stable, indicating a commitment to brand investment and market penetration. Additionally, the company has successfully achieved growth in both price and volume from the second quarter of 2023 through the third quarter of 2024, reflecting strong demand for its products. With international sales comprising about 70% of total revenue and emerging markets making up approximately 45%, Colgate-Palmolive is well-positioned for continued growth and expansion in diverse markets.

Bears say

Colgate-Palmolive's gross margin experienced a significant decline of 75 basis points year-over-year in the second quarter of 2025, primarily attributed to rising raw material costs and tariffs. In addition, the company reported volume declines of 0.3% and 0.9% in the first and second quarters of 2025, respectively, despite achieving positive price growth during the same periods. Furthermore, the dog food category, which constitutes a notable portion of Colgate-Palmolive's sales through its Hill's brand, has seen a troubling trend, with US measured retail channels reporting a 2.8% decline in 3Q25 to date, representing a continued acceleration of negative sales momentum in this segment.

Colgate-Palmolive (CL) has been analyzed by 15 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 40% recommend Buy, 27% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Colgate-Palmolive and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Colgate-Palmolive (CL) Forecast

Analysts have given Colgate-Palmolive (CL) a Buy based on their latest research and market trends.

According to 15 analysts, Colgate-Palmolive (CL) has a Buy consensus rating as of Mar 17, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $94.27, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $94.27, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Colgate-Palmolive (CL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.